Novartis COX-189 Is Co-Promotion Candidate; Zelnorm Will Not Have Partner

Novartis intends to launch Zelnorm without a co-promotion partner following an internal review of the company's strategic options, CEO Daniel Vasella said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet